Trials / Conditions / Ovulation Induction

Ovulation Induction

23 registered clinical trials studyying Ovulation Induction — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	LE + CC vs. LE for Ovulation Induction NCT06934785	Mỹ Đức Hospital	N/A
Completed	Oxytocin Versus Human Chorionic Gonadotropin as Trigger in Ovulation Induction NCT06725004	Shakeela Ishrat	Phase 3
Terminated	Myo-inositol Versus Clomiphene Citrate in PCOS NCT04306692	University Hospital, Ghent	Phase 4
Completed	Letrozole Versus Gonadotropins in Clomiphene Citrate Resistance NCT04834791	Tanta University	Phase 4
Completed	Effect of Adding Isoflavonoids to Clomiphene Citrate for Ovulation Induction in Women With Polycystic Ovary Sy NCT04610957	FAlbasri	N/A
Unknown	Agonist Versus Classical HCG Trigger (Poor Responders, Normoresponders and High Responders) NCT03307720	Ginegorama S.L.	N/A
Unknown	Effect of Vitamin D Supplement in Induction of Ovulation in Overweight Women With Polycystic Ovary Syndrome NCT03396380	Ain Shams University	Phase 3
Completed	Follicular Long GnRH Agonist Versus Antagonist Protocol in PCOS Women Undergoing in Vitro Fertilization NCT02496754	The First Affiliated Hospital of Zhengzhou University	N/A
Completed	GnRH Agonist Versus hCG Trigger in Ovulation Induction With Intrauterine Insemination. NCT03825445	Hue University of Medicine and Pharmacy	N/A
Completed	Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation NCT01645241	Fundacion Dexeus	N/A
Completed	Traditional Clomiphene Citrate Administration vs. Stair-step Approach NCT01008319	University of Oklahoma	Phase 3
Completed	Recombinant Follicle Stimulating Hormone (FSH) (Gonal-f®): Use in Ovulation Induction NCT01081626	Merck KGaA, Darmstadt, Germany	Phase 4
Terminated	Trial Comparing Start Stimulation of Recombinant Follicle Stimulating Hormone (rFSH) on Cycle Day 2 Versus Cyc NCT00823472	UMC Utrecht	Phase 4
Terminated	A Clinical Trial to Determine the Effect of Lutropin Alfa on Embryo Quality and Implantation Rate in Advanced NCT01075815	Merck KGaA, Darmstadt, Germany	Phase 2
Terminated	AS900672-Enriched in Ovulation Induction NCT00553514	Merck KGaA, Darmstadt, Germany	Phase 2
Terminated	A Phase II Study to Assess the Efficacy and Safety of Luveris® (Lutropin Alfa) in Mid Follicular Phase for Con NCT01079949	Merck KGaA, Darmstadt, Germany	Phase 2
Terminated	A Phase 2 Trial to Evaluate if Corifollitropin Alfa (Org 36286), Followed by a Low Daily Dose of hCG or Recomb NCT00697255	Organon and Co	Phase 2
Completed	SJ-0021 (Gonalef®) Versus Purified Pituitary Gonadotropin (Fertinorm-P®) for Ovulation Induction in Japanese I NCT01185782	Merck KGaA, Darmstadt, Germany	Phase 3
Completed	A Randomised, Phase II, Comparative Study With a Parallel Control for Evaluating the Efficacy and Safety of Co NCT01110707	Merck KGaA, Darmstadt, Germany	Phase 2
Completed	Convenience and Safety of Assisted Reproductive Technology Procedures Using a Gonal-F Filled by Mass (Fbm) Liq NCT01183143	Merck KGaA, Darmstadt, Germany	Phase 3
Completed	A Prospective, Multi-centric Observational Study to Determine the Mono-bifollicular Development in Infertile W NCT01111084	Merck KGaA, Darmstadt, Germany	—
Completed	An Open Label, Canadian Phase IIIb Study With Ovidrel in Ovulation Induction (OI) and Assisted Reproductive Te NCT01152866	EMD Serono	—
Completed	To Evaluate the Convenience, Safety and Efficacy of Follitropin Alfa Liquid Pen Compared With Follitropin Beta NCT01081639	Merck KGaA, Darmstadt, Germany	Phase 3